Cancer News > Cancer Drugs

March 25, 2005

Pfizer and Coley to Develop ProMune Cancer Drug

Pfizer has agreed to pay $50 million to Coley Pharmaceutical Group with the potential for up to $455 million in additional milestone payments, plus royalties, in an exclusive global license agreement to develop, manufacture and commercialize Coley's anti-cancer drug ProMune (CPG 7909). (Daily News Central)



Talk about this story




Remember Me?



Follow the Conversation!
Be Notified When New Comments Are Made on This News Story
Related Stories
Fight Prostate Cancer With Pomegranate Juice
New Leukemia Drug Approved
Hard Choices After Prostate Cancer Diagnosis
Prostate Cancer Recovery Hurt By Obesity
Patsy Ramsey Dies From Ovarian Cancer
Syndicate Cancer News



Subscribe in NewsGator Online

Add Cancer News to your My Yahoo! page

More News Topics:
Breast Cancer      Alternative Medicine      Infectious Disease       Eating Disorders       Sleep      Orthopedic      Allergies      Neurological Disorders      Chronic Pain       Senior Health       Heart Health      Mental Health       Autoimmune Disorders       Women's Health
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 HealthDiaries.com. All rights reserved.